메뉴 건너뛰기




Volumn 25, Issue 2, 2015, Pages 279-287

Clinical outcomes of uterine carcinosarcoma: Results of 94 patients

Author keywords

Adjuvant therapy; Carcinosarcoma; Malignant mixed mullerian tumor; Survival; Uterine neoplasm

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; PACLITAXEL;

EID: 84925855902     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000347     Document Type: Article
Times cited : (21)

References (31)
  • 2
    • 37549048643 scopus 로고    scopus 로고
    • The management of patients with uterine sarcoma: A debated clinical challenge
    • Gadducci A, Cosio S, Romanini A, et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65:129-142.
    • (2008) Crit Rev Oncol Hematol. , vol.65 , pp. 129-142
    • Gadducci, A.1    Cosio, S.2    Romanini, A.3
  • 3
    • 0018122732 scopus 로고
    • Uterine sarcomas: Natural history, treatment and prognosis
    • Salazar OM, Bonfiglio TA, Patten SF, et al. Uterine sarcomas: natural history, treatment and prognosis. Cancer. 1978;42:1152-1160.
    • (1978) Cancer , vol.42 , pp. 1152-1160
    • Salazar, O.M.1    Bonfiglio, T.A.2    Patten, S.F.3
  • 4
    • 52049118515 scopus 로고    scopus 로고
    • Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis
    • Nemani D, Mitra N, Guo M, et al. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol. 2008;111:82-88.
    • (2008) Gynecol Oncol. , vol.111 , pp. 82-88
    • Nemani, D.1    Mitra, N.2    Guo, M.3
  • 5
    • 0031260023 scopus 로고    scopus 로고
    • Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study
    • Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol. 1997;67:70-75.
    • (1997) Gynecol Oncol. , vol.67 , pp. 70-75
    • Sartori, E.1    Bazzurini, L.2    Gadducci, A.3
  • 6
    • 75749084357 scopus 로고    scopus 로고
    • The impact of multi-modal therapy on survival for uterine carcinosarcomas
    • Bosquet JG, Terstriep SA, Cliby WA, et al. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010;116:419-423.
    • (2010) Gynecol Oncol. , vol.116 , pp. 419-423
    • Bosquet, J.G.1    Terstriep, S.A.2    Cliby, W.A.3
  • 7
    • 0031127636 scopus 로고    scopus 로고
    • Uterine carcinosarcomas: Incidence and trends in management and survival
    • Arrastia CD, Fruchter RG, Clark M, et al. Uterine carcinosarcomas: incidence and trends in management and survival. Gynecol Oncol. 1997;65:158-163.
    • (1997) Gynecol Oncol. , vol.65 , pp. 158-163
    • Arrastia, C.D.1    Fruchter, R.G.2    Clark, M.3
  • 8
    • 0035169864 scopus 로고    scopus 로고
    • Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study
    • Bodner-Adler B, Bodner K, Obermair A, et al. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res. 2001;21:3069-3074.
    • (2001) Anticancer Res. , vol.21 , pp. 3069-3074
    • Bodner-Adler, B.1    Bodner, K.2    Obermair, A.3
  • 9
    • 0036326732 scopus 로고    scopus 로고
    • Analysis of clinicopathologic factors in malignant mixed mullerian tumors of the uterine corpus
    • Inthasorn P, Carter J, Valmadre S, et al. Analysis of clinicopathologic factors in malignant mixed mullerian tumors of the uterine corpus. Int J Gynecol Cancer. 2002;12:348-353.
    • (2002) Int J Gynecol Cancer , vol.12 , pp. 348-353
    • Inthasorn, P.1    Carter, J.2    Valmadre, S.3
  • 10
    • 79955550125 scopus 로고    scopus 로고
    • Revised FIGO staging system for endometrial cancer
    • Lewin SN. Revised FIGO Staging System for endometrial cancer. Clin Obstet Gynecol. 2011;54:215-218.
    • (2011) Clin Obstet Gynecol. , vol.54 , pp. 215-218
    • Lewin, S.N.1
  • 11
    • 81155123086 scopus 로고    scopus 로고
    • The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
    • Tanner EJ, Leitao MM Jr, Garg K, et al. The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecol Oncol. 2011;123:548-552.
    • (2011) Gynecol Oncol. , vol.123 , pp. 548-552
    • Tanner, E.J.1    Leitao, M.M.2    Garg, K.3
  • 12
    • 41849100978 scopus 로고    scopus 로고
    • Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
    • Reed NS, Mangioni C, Malmström H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008;44:808-818.
    • (2008) Eur J Cancer , vol.44 , pp. 808-818
    • Reed, N.S.1    Mangioni, C.2    Malmström, H.3
  • 13
    • 0022006615 scopus 로고
    • A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynaecologic Oncology Group Study
    • Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynaecologic Oncology Group Study. J Clin Oncol. 1985;3:1240-1245.
    • (1985) J Clin Oncol. , vol.3 , pp. 1240-1245
    • Omura, G.A.1    Blessing, J.A.2    Major, F.3
  • 14
    • 84865687098 scopus 로고    scopus 로고
    • A multi-institutional cohort study of adjuvant therapy in stage IYII uterine carcinosarcoma
    • Cantrell LA, Havrilesky L, Moore DT, et al. A multi-institutional cohort study of adjuvant therapy in stage IYII uterine carcinosarcoma. Gynecol Oncol. 2012;127:22-26.
    • (2012) Gynecol Oncol. , vol.127 , pp. 22-26
    • Cantrell, L.A.1    Havrilesky, L.2    Moore, D.T.3
  • 15
    • 35348917431 scopus 로고    scopus 로고
    • A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. Cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage IYIV carcinosarcoma (CS) of the uterus
    • Wolfson AH, Brady MF, Rocereto T, et al. A Gynecologic Oncology Group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage IYIV carcinosarcoma (CS) of the uterus. Gynecol Oncol. 2007;107:177-185.
    • (2007) Gynecol Oncol. , vol.107 , pp. 177-185
    • Wolfson, A.H.1    Brady, M.F.2    Rocereto, T.3
  • 16
    • 37349058160 scopus 로고    scopus 로고
    • Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience
    • Hoskins PJ, Le N, Ellard S, et al. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecol Oncol. 2008;108:58-62.
    • (2008) Gynecol Oncol. , vol.108 , pp. 58-62
    • Hoskins, P.J.1    Le, N.2    Ellard, S.3
  • 17
    • 84880367975 scopus 로고    scopus 로고
    • Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey
    • Kucukoztas N, Dizdar O, Rahatli S, et al. Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey. Asian Pac J Cancer Prev. 2013;14:2959-2962.
    • (2013) Asian Pac J Cancer Prev. , vol.14 , pp. 2959-2962
    • Kucukoztas, N.1    Dizdar, O.2    Rahatli, S.3
  • 18
    • 33745058649 scopus 로고    scopus 로고
    • Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus
    • Wong L, See HT, Khoo-Tan HS, et al. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus. Int J Gynecol Cancer. 2006;16:1364-1369.
    • (2006) Int J Gynecol Cancer , vol.16 , pp. 1364-1369
    • Wong, L.1    See, H.T.2    Khoo-Tan, H.S.3
  • 19
    • 84875944999 scopus 로고    scopus 로고
    • A population-based series of uterine carcinosarcomas with long-term follow-up
    • Sorbe B, Paulsson G, Andersson S, et al. A population-based series of uterine carcinosarcomas with long-term follow-up. Acta Oncol. 2013;52:759-766.
    • (2013) Acta Oncol. , vol.52 , pp. 759-766
    • Sorbe, B.1    Paulsson, G.2    Andersson, S.3
  • 20
    • 61849158753 scopus 로고    scopus 로고
    • Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma
    • Galaal K, Kew FM, Tam KF, et al. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma. Eur J Obstet Gynecol Reprod Biol. 2009;143:88-92.
    • (2009) Eur J Obstet Gynecol Reprod Biol. , vol.143 , pp. 88-92
    • Galaal, K.1    Kew, F.M.2    Tam, K.F.3
  • 21
    • 48549106142 scopus 로고    scopus 로고
    • Uterine carcinosarcomas and grade 3 endometrioid cancers: Evidence for distinct tumor behavior
    • Bansal N, Herzog TJ, Seshan VE, et al. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior. Obstet Gynecol. 2008;112:64-70.
    • (2008) Obstet Gynecol. , vol.112 , pp. 64-70
    • Bansal, N.1    Herzog, T.J.2    Seshan, V.E.3
  • 22
    • 0031455206 scopus 로고    scopus 로고
    • An evaluation of prognostic factors in uterine carcinosarcoma
    • Nordal RR, Kristensen GB, Stenwig AE, et al. An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol. 1997;67:316-321.
    • (1997) Gynecol Oncol. , vol.67 , pp. 316-321
    • Nordal, R.R.1    Kristensen, G.B.2    Stenwig, A.E.3
  • 23
    • 69449098378 scopus 로고    scopus 로고
    • Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy
    • Leath CA 3rd, Numnum TM, Kendrick JE 4th, et al. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy. Int J Gynecol Cancer. 2009;19:888-891.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 888-891
    • Leath, C.A.1    Numnum, T.M.2    Kendrick, J.E.3
  • 24
    • 0038637704 scopus 로고    scopus 로고
    • Surgery for uterine sarcoma: Review of the literature and recommendations for the standard surgical procedure
    • Morice P, Rodrigues A, Pautier P, et al. Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure. Gynecol Obstet Fertil. 2003;31:147-150.
    • (2003) Gynecol Obstet Fertil. , vol.31 , pp. 147-150
    • Morice, P.1    Rodrigues, A.2    Pautier, P.3
  • 25
    • 0027402723 scopus 로고
    • Prognostic factors in early-stage uterine sarcoma: A Gynecologic Oncology Group study
    • Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer. 1993;71:1702-1709.
    • (1993) Cancer , vol.71 , pp. 1702-1709
    • Major, F.J.1    Blessing, J.A.2    Silverberg, S.G.3
  • 26
    • 0032211276 scopus 로고    scopus 로고
    • Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri
    • Knocke TH, Kucera H, Dorfler D, et al. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer. 1998;83:1972-1979.
    • (1998) Cancer , vol.83 , pp. 1972-1979
    • Knocke, T.H.1    Kucera, H.2    Dorfler, D.3
  • 27
    • 0033048439 scopus 로고    scopus 로고
    • Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Group Oncologic Catala-Occita
    • Ferrer F, Sabater S, Farrús B, et al. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Group Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys. 1999;44:47-52.
    • (1999) Int J Radiat Oncol Biol Phys. , vol.44 , pp. 47-52
    • Ferrer, F.1    Sabater, S.2    Farrús, B.3
  • 28
    • 0031172699 scopus 로고    scopus 로고
    • The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcomas
    • Chi DS, Mychalczak B, Saigo PE, et al. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcomas. Gynecol Oncol. 1997;65:493-498.
    • (1997) Gynecol Oncol. , vol.65 , pp. 493-498
    • Chi, D.S.1    Mychalczak, B.2    Saigo, P.E.3
  • 29
    • 33947491518 scopus 로고    scopus 로고
    • Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group Study
    • Homesley HD, Filiaci V, Markman M, et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:526-531.
    • (2007) J Clin Oncol. , vol.25 , pp. 526-531
    • Homesley, H.D.1    Filiaci, V.2    Markman, M.3
  • 30
    • 77954948152 scopus 로고    scopus 로고
    • Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A Gynecologic Oncology Group study
    • Powell MA, Filiaci VL, Rose PG, et al. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol. 2010;28:2727-2731.
    • (2010) J Clin Oncol. , vol.28 , pp. 2727-2731
    • Powell, M.A.1    Filiaci, V.L.2    Rose, P.G.3
  • 31
    • 55649083105 scopus 로고    scopus 로고
    • A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage IYIV uterine carcinosarcoma
    • Makker V, Abu-Rustum NR, Alektiar KM, et al. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage IYIV uterine carcinosarcoma. Gynecol Oncol. 2008;111:249-254.
    • (2008) Gynecol Oncol. , vol.111 , pp. 249-254
    • Makker, V.1    Abu-Rustum, N.R.2    Alektiar, K.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.